The FDA granted accelerated approval to Nelkarmi for adults with advanced ALK-positive non-small cell lung cancer that grew after prior ALK-targeted drugs.
Answers to common questions about flu, COVID-19, RSV and other vaccines for people in cancer treatment, including which shots to avoid, the best timing around chemotherapy and what family members should do.
An expert from Case Western Reserve University explains how cancer cells survive treatment, why rare diseases are hard to study and why CAR-T therapy offers hope.
The FDA approved Wilserdly with everolimus for some ER-positive, HER2-negative, ESR1-mutated advanced breast cancers that grew after prior hormone therapy.
An updated ASTRO guideline released Oct. 27, 2026, says most men getting radiation for prostate cancer that has not spread can safely finish treatment in weeks instead of months, and many can finish in five sessions. Here is what that means for patients.
City of Hope experts share integrative therapies that may ease breast cancer side effects such as joint pain, hot flashes, poor sleep, fatigue and anxiety.